Alere shares climbed 4.4 percent to $37.74, the company’s biggest gain since Sept. 7. when shares rose 5 percent.
Abbott Laboratories requested the documents as part of a breach-of-contract lawsuit against Alere on account of its operations and billing practices Nov. 3, according to TheStreet. Alere had previously filed a lawsuit against the pharmaceutical company in August claiming Abbott Laboratories’ executives attempted to stymie the deal. The lawsuit is still pending.
Alere officials said they consider the lawsuit to be “entirely without merit,” but agreed to turn over the documents to help close the deal as quickly as possible, according to Chicago Tribune.
More articles on finance:
7 recent RCM product launches
Change Healthcare adds capabilities to SmartPay app: 3 things to know
Medicare’s top 15 costliest drugs in 2015
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
